Richard Rosenzweig
General Counsel at DENTSPLY SIRONA INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Richard C.
Rosenzweig currently works at Dentsply Sirona, Inc., as Secretary, Senior Vice President & General Counsel from 2023.
Mr. Rosenzweig also formerly worked at Johnson & Johnson, as Director-Worldwide Licensing & Acquisitions, Rutgers Cancer Institute of New Jersey, as Member-Director’s Leadership Counsel, Rutgers Biomedical & Health Sciences, as Member-Director’s Leadership Council, C.
R.
Bard, Inc. (New Jersey), as Vice President-Law & Assistant Secretary from 2007 to 2017, Rochester Medical Corp., as Assistant Secretary, IMPATH, Inc., as Secretary, Senior Vice President & General Counsel in 2004, Phibro Animal Health Corp., as Secretary, Senior Vice President & General Counsel in 2004, Liberator Medical Holdings, Inc., as Vice President, AngioDynamics, Inc., as Secretary, Senior Vice President & General Counsel from 2021 to 2023, Kramer Levin Naftalis & Frankel LLP, as Attorney, and The Cancer Institute of New Jersey Foundation, as Trustee.
Mr. Rosenzweig received his undergraduate degree from Brandeis University and graduate degree from Boston University School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
DENTSPLY SIRONA, INC.
0.03% | 2024-04-11 | 55,417 ( 0.03% ) | 2 M $ | 2024-03-30 |
ANGIODYNAMICS, INC.
0.04% | 2023-01-31 | 15,730 ( 0.04% ) | 92 335 $ | 2024-03-30 |
Richard Rosenzweig active positions
| Companies | Position | Start |
|---|---|---|
| DENTSPLY SIRONA INC. | General Counsel | 2023-02-28 |
Former positions of Richard Rosenzweig
| Companies | Position | End |
|---|---|---|
| ANGIODYNAMICS, INC. | General Counsel | 2023-01-31 |
| C.R. BARD | General Counsel | 2017-11-30 |
| IMPATH, Inc. | General Counsel | 2003-12-31 |
| Rutgers Biomedical & Health Sciences | Corporate Officer/Principal | - |
Rutgers Cancer Institute of New Jersey
 Rutgers Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Rutgers Cancer Institute of New Jersey, in partnership with RWJBarnabas Health, is the only National Cancer Institute-designated comprehensive cancer center in New Jersey. Rutgers Cancer Institute has locations in New Brunswick and at University Hospital in Newark, as well as through RWJBarnabas Health facilities. The institute offers advanced cancer treatment options, including bone marrow transplantation, proton therapy, CAR T-cell therapy, and complex surgical procedures. Patients have access to cutting-edge therapies such as precision medicine and immunotherapy, many of which are not widely available. The top cancer researchers and clinicians throughout the state collaborate to apply the latest technologies, therapies, and approaches to improve cancer diagnosis and treatment. | Corporate Officer/Principal | - |
Training of Richard Rosenzweig
| Brandeis University | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| PHIBRO ANIMAL HEALTH CORPORATION | Health Technology |
| ANGIODYNAMICS, INC. | Health Technology |
| DENTSPLY SIRONA INC. | Health Technology |
| Private companies | 8 |
|---|---|
C. R. Bard, Inc. (New Jersey)
 C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ. | Health Technology |
Rochester Medical Corp.
 Rochester Medical Corp. Medical SpecialtiesHealth Technology Rochester Medical Corp. manufactures disposable medical catheters and devices for urological and continence care applications. The company was founded by Anthony J. Conway, Philip J. Conway and Richard D. Fryar, Jr. in April 1988 and is headquartered in Murray Hill, NJ. | Health Technology |
| IMPATH, Inc. | Health Services |
Liberator Medical Holdings, Inc.
 Liberator Medical Holdings, Inc. Specialty StoresRetail Trade Liberator Medical Holdings, Inc. operates as a holding company, which through its subsidiaries, provides medical supplies primarily to medicare-eligible seniors. It bill medicare and third-party insurers on behalf of its patients. The company is headquartered in Stuart, FL. | Retail Trade |
Kramer Levin Naftalis & Frankel LLP
 Kramer Levin Naftalis & Frankel LLP Miscellaneous Commercial ServicesCommercial Services Kramer Levin Naftalis & Frankel LLP engages in the provision of legal services. It provides services to banking and finance, bankruptcy and restructuring, employment law, environmental, immigration, intellectual property, litigation, and real estate. The company was founded by Arthur Kramer and Lou Lowenstein in 1968 and is headquartered in New York, NY. | Commercial Services |
| The Cancer Institute of New Jersey Foundation | |
Rutgers Cancer Institute of New Jersey
Rutgers Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Rutgers Cancer Institute of New Jersey, in partnership with RWJBarnabas Health, is the only National Cancer Institute-designated comprehensive cancer center in New Jersey. Rutgers Cancer Institute has locations in New Brunswick and at University Hospital in Newark, as well as through RWJBarnabas Health facilities. The institute offers advanced cancer treatment options, including bone marrow transplantation, proton therapy, CAR T-cell therapy, and complex surgical procedures. Patients have access to cutting-edge therapies such as precision medicine and immunotherapy, many of which are not widely available. The top cancer researchers and clinicians throughout the state collaborate to apply the latest technologies, therapies, and approaches to improve cancer diagnosis and treatment. | Health Services |
| Rutgers Biomedical & Health Sciences |
- Stock Market
- Insiders
- Richard Rosenzweig
